Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | IDE | P14735 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30919275 | 0.91 | NOD1 (0.44) | KMT2APOLBL3MBTL1NOD1SMN1; SMN2 | |
| SCHEMBL30919307 | 0.91 | NOD1 (0.44) | KMT2APOLBL3MBTL1NOD1SMN1; SMN2 | |
| SCHEMBL30919305 | 0.89 | KMT2A (0.38) | KMT2APOLBL3MBTL1NOD1SMN1; SMN2 | |
| SCHEMBL30919266 | 0.89 | KMT2A (0.38) | KMT2APOLBL3MBTL1NOD1SMN1; SMN2 | |
| SCHEMBL30919316 | 0.88 | NOD1 (0.38) | KMT2APOLBL3MBTL1NOD1SMN1; SMN2 | |
| SCHEMBL30919290 | 0.83 | NMT2 (0.34) | KMT2APOLBL3MBTL1NOD1 | |
| SCHEMBL30919314 | 0.82 | SMN1; SMN2 (0.35) | NOD1SMN1; SMN2IDE | |
| SCHEMBL30919306 | 0.80 | NOD1 (0.33) | NOD1SMN1; SMN2 | |
| SCHEMBL18451341 | 0.79 | L3MBTL1 (0.43) | KMT2APOLBL3MBTL1NOD1 | |
| SCHEMBL20465422 | 0.79 | L3MBTL1 (0.43) | KMT2APOLBL3MBTL1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612124-A1 | AZOTOMYCIN PRODRUGS WITH PREFERENTIAL TUMOR DELIVERY | The Johns Hopkins University (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097320-A1 | AZOTOMYCIN PRODRUGS WITH PREFERENTIAL TUMOR DELIVERY | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-10 | — | — | WO | disclosed |